Stage II Prostate Cancer AJCC v7

general

Stage IIB includes: (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T2c: Tumor involves both lobes. T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves

Centers

Active Trials

$3.8B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Stage III Prostate Cancer AJCC v7	42	47
Stage IIA Prostate Cancer AJCC v7	17	14

Top Centers for Stage II Prostate Cancer AJCC v7(43)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
2	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
3	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
4	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
5	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
6	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
7	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
8	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
9	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	4	—	51.6
10	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	4	—	51.6
11	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	51.6
12	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
13	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	4	—	51.6
14	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
15	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	51.6
16	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
17	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	4	—	51.6
18	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	2	—	51.6
19	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	4	—	51.6
20	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	2	—	51.6
21	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	4	—	51.6
22	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	2	—	51.6
23	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	2	—	51.6
24	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	51.6
25	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	4	—	51.6
26	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	51.6
27	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	2	—	51.6
28	Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program	Active Research Program	2	—	51.6
29	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	2	—	51.6
30	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	2	—	51.6
31	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	2	—	51.6
32	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	2	—	51.6
33	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		2	$737M	—
34	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		2	$655M	—
35	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive		—	$458M	—
36	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	$454M	—
37	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive		2	$392M	—
38	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		2	$375M	—
39	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	$262M	—
40	Medical College of Wisconsin Cancer CenterMilwaukee, WI		2	$181M	—
41	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		3	$123M	—
42	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		2	$103M	—
43	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	$94M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →